000 01323 a2200361 4500
005 20250515025738.0
264 0 _c20060928
008 200609s 0 0 eng d
022 _a0307-6938
024 7 _a10.1111/j.1365-2230.2006.02114.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFürst, B
245 0 0 _aThe impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
_h[electronic resource]
260 _bClinical and experimental dermatology
_cJul 2006
300 _a509-14 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aBorrelia burgdorferi Group
_ximmunology
650 0 4 _aErythema Chronicum Migrans
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunocompromised Host
_ximmunology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRetrospective Studies
700 1 _aGlatz, M
700 1 _aKerl, H
700 1 _aMüllegger, R R
773 0 _tClinical and experimental dermatology
_gvol. 31
_gno. 4
_gp. 509-14
856 4 0 _uhttps://doi.org/10.1111/j.1365-2230.2006.02114.x
_zAvailable from publisher's website
999 _c16315055
_d16315055